Please use this identifier to cite or link to this item:
Title: Prolonged cholestasis after raloxifene and fenofibrate interaction: A case report.
Authors: Lucena González, María Isabel
Andrade Bellido, Raul Jesús
Vicioso Recio, Luis
González, F Jesús
Pachkoria, Ketevan
García-Muñoz, Beatriz
metadata.dc.contributor.authoraffiliation: [Lucena González,MI; Pachkoria,K] Clinical Pharmacology Service, Hospital Univeristario Virgen de la Victoria, Málaga, Spain. [Andrade Bellido,RJ; García-Muñoz,B] Liver Unit, Gastroenterology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. [Vicioso Recio,L] Department of Pathology, Hospital Universitario Virgen de la Victoria, Málaga, Spain. [González,FJ] Institute of Biopathology and Regenerative Medicine, University of Granada, Spain.
Keywords: Drug-drug Interactions;Hepatotoxicity;Causality Assessment;Colestasis;Fenofibrato;Hígado;Hipolipemiantes;Raloxifeno;Biopsia;Moduladores Selectivos de los Receptores de Estrógeno;Mediana edad;Humanos;Femenino
metadata.dc.subject.mesh: Medical Subject Headings::Diseases::Digestive System Diseases::Biliary Tract Diseases::Bile Duct Diseases::Cholestasis
Medical Subject Headings::Check Tags::Female
Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Carboxylic Acids::Acids, Acyclic::Butyrates::Isobutyrates::Fibric Acids::Fenofibrate
Medical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans
Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Antimetabolites::Hypolipidemic Agents
Medical Subject Headings::Anatomy::Digestive System::Liver
Medical Subject Headings::Named Groups::Persons::Age Groups::Adult::Middle Aged
Medical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Cyclic::Hydrocarbons, Aromatic::Benzene Derivatives::Benzylidene Compounds::Stilbenes::Tamoxifen::Raloxifene
Medical Subject Headings::Chemicals and Drugs::Hormones, Hormone Substitutes, and Hormone Antagonists::Hormone Antagonists::Estrogen Receptor Modulators::Selective Estrogen Receptor Modulators
Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Surgical Procedures, Operative::Biopsy
Issue Date: 28-Aug-2006
Publisher: Baishideng Publishing Group Co. Limited
Citation: Lucena González MI, Andrade Bellido RJ, Vicioso Recio L, González FJ, Pachkoria K, García-Muñoz B. Prolonged cholestasis after raloxifene and fenofibrate interaction: A case report. World J. Gastroenterol. 2006; 12(32):5244-6
Abstract: Assigning causality in drug-induced liver injury is challenging particularly when more than one drug could be responsible. We report a woman on long-term therapy with raloxifen who developed acute cholestasis shortly after starting fenofibrate. The picture evolved into chronic cholestasis. We hypothesized that an interaction at the metabolic level could have triggered the presentation of hepatotoxicity after a very short time of exposure to fenofibrate in this patient. The findings of an overexpression of vascular endothelial growth factor in the liver biopsy suggest that angiogenesis might play a role in the persistence of toxic cholestasis.
Description: Case Reports; Journal Article; Research Support, Non-U.S. Gov't;
ISSN: 2219-2840 (Online)
1007-9327 (Print
Appears in Collections:01- Artículos - Hospital Virgen de la Victoria

Files in This Item:
File Description SizeFormat 
Lucena_Prolonged.pdfArtículo publicado376,72 kBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons